REAL · The RealReal, Inc.

Current Thesis

The RealReal’s recovery case is that luxury-resale growth can regain market support: a weekly close above the broken $10.00 shelf and delivery against third-quarter guidance would establish it; a weekly close below $8.02 would end it. The September 18, 2026 adjusted close was $9.45, leaving the recovery unconfirmed.

The operating evidence remains the August 6 report: second-quarter gross merchandise value (GMV) reached $617 million, up 22% year over year, and management raised its full-year outlook. These are reported results and management forecasts, respectively—not evidence that the equity has recovered. Company results.

As a price-supported growth story, the narrative is dead: the September 4 weekly close of $9.86 broke the published $10.00 shelf, and the September 18 close remained below it. That classification is an inference from the supplied adjusted-price record, not a claim that the business has stopped growing. The recovery hypothesis retains low conviction because its price confirmation is absent.

Bullish and bearish views on The RealReal, Inc.

The model's bull view on The RealReal, Inc. (REAL), in brief: Resale demand continued expanding. The August 6, 2026 release reported second-quarter GMV of $617 million, up 22% year over year, and trailing-twelve-month active buyers of 1,107,000, up 11%. Those figures support the operating-growth component of the recovery case. Company… The bear view: Price confirmation remains absent. The supplied September 18, 2026 adjusted-price record shows a three-month decline of 23.5% and a close 44.1% below the $16.90 rolling annual high. These observations contradict an established equity recovery. Reported losses complicate adjusted… Both cases follow in full.

Bull Case

• Resale demand continued expanding. The August 6, 2026 release reported second-quarter GMV of $617 million, up 22% year over year, and trailing-twelve-month active buyers of 1,107,000, up 11%. Those figures support the operating-growth component of the recovery case. Company results.
• Adjusted profitability improved alongside growth. Second-quarter adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) reached $13.5 million, or 7.0% of revenue, versus a 4.1% margin a year earlier, according to the August 6 release. Company results.
• Analyst support received a refresh. Benzinga records BTIG maintaining its positive recommendation and $17 analyst price target on September 17, 2026. This updates the September 6 dossier’s stale analyst chronology; the reiteration supplies no new company result. Benzinga analyst record.

Bear Case

• Price confirmation remains absent. The supplied September 18, 2026 adjusted-price record shows a three-month decline of 23.5% and a close 44.1% below the $16.90 rolling annual high. These observations contradict an established equity recovery.
• Reported losses complicate adjusted progress. The August 6, 2026 release reported a second-quarter net loss of $27 million, including an $18.6 million noncash warrant-liability adjustment. The loss therefore cannot be read directly as cash consumption. Company results.
• Revenue mix limits margin interpretation. Second-quarter direct revenue grew 26%, against 15% for consignment revenue, while gross margin reached 74.4%, only slightly above the prior-year quarter, in the August 6, 2026 release. Adjusted EBITDA expansion has not translated into comparable gross-margin expansion. Company results.

Setup & Price Structure

The September 18, 2026 adjusted close of $9.45 remains beneath the $10.00 shelf broken on September 4. The 14-day relative strength index (RSI) was 17.8 on September 18; that momentum reading alone does not establish a reversal. The supplied observations are insufficient to estimate a rebound probability statistically.

The $8.02 reference remains the historical threshold documented in the September 6 dossier, not a newly verified rolling annual low. A weekly close above $10.00 would satisfy the recovery case’s price component; a weekly close below $8.02 would invalidate it.

BTIG’s September 17 reiteration is observable analyst support, not measured investor positioning. Current short interest, retail participation, moving-average distances and discretionary insider transactions are not established by the available evidence; no crowding conclusion follows. Benzinga analyst record.

Catalyst Calendar (next 30 days)

• 2026-09-20 through 2026-10-20: No company-confirmed event inside this window was identified on the investor-relations calendar checked September 20. The calendar still lists the August 6 second-quarter call as its latest earnings event. This is a scheduling observation, not a prediction of no news. Company calendar.
• ~2026-11-09, estimated: MarketBeat lists third-quarter earnings on this date and explicitly says the company has not confirmed it. This later event is the operating test: management’s August 6 guidance calls for GMV of $610–620 million, revenue of $194–198 million and adjusted EBITDA of $13.5–14.5 million. Earnings calendar; company guidance.

What Would Change Our Mind

Loss of the historical downside reference would end the recovery hypothesis: a weekly close below $8.02 is the price invalidation. A third-quarter GMV result below management’s August 6 floor of $610 million, or a cut to its full-year adjusted-EBITDA outlook of $66–69 million, would separately undermine the operating premise.

The case would play out through a weekly close above the broken $10.00 shelf together with third-quarter results meeting the August 6 guidance floors and preservation of the full-year adjusted-EBITDA outlook, before the price invalidation occurs. Neither the September 18 RSI reading nor the September 17 analyst reiteration establishes those outcomes.

Correlation Notes

This remains a single-company recovery hypothesis. The September 18, 2026 price record contains no matched sector-return series, so it cannot establish that consumer-discretionary rotation caused the decline. The August 6 buyer-growth and merchandise-value figures describe company demand; they do not measure equity correlation. No group-move confirmation is established.